Skip to main content

Table 5 Comparing 5-year mortality rates in subjects without liver metastasis to subjects with liver metastasis

From: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites

Variable

Without liver metastasis

With liver metastasis

P value

Total 5-year mortality

53/119 (45%)

75/122 (61%)

0.009

Portal HTN

14/39 (36%)

21/30 (70%)

0.007

Sinusoidal portal HTN

2/4 (50%)

7/9 (78%)

0.5

Peritoneal carcinomatosis

34/73 (46.5%)

47/77 (61%)

0.1

CA: Breast cancer

4/12 (33%)

16/29 (55%)

0.3

CA: Gastric cancer

11/24 (46%)

4/9 (44%)

1

CA: Lung cancer

15/32 (47%)

9/16 (56%)

0.8

CA: Ovarian cancer

8/15 (53%)

5/5 (100%)

0.1

CA: Pancreatic cancer

6/14 (43%)

17/26 (65%)

0.2

CA: Renal cancer

7/13 (54%)

8/13 (62%)

1

CA: Colon cancer

2/9 (22%)

16/24 (67%)

0.04